Wingesic Ultra Tablet is a combination analgesic formulation containing Aceclofenac 100 mg, Paracetamol 325 mg, and Tramadol 37.5 mg, designed for the effective management of moderate to severe pain and inflammation. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), exerts its effect by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis responsible for pain and inflammation. Paracetamol provides analgesic and antipyretic effects through central inhibition of prostaglandin synthesis, enhancing overall pain relief. Tramadol, a centrally acting opioid analgesic, binds to mu-opioid receptors and inhibits the reuptake of norepinephrine and serotonin, contributing to its potent analgesic properties. This combination is indicated for conditions such as musculoskeletal disorders, postoperative pain, osteoarthritis, rheumatoid arthritis, and other painful inflammatory conditions. Wingesic Ultra offers rapid onset and sustained pain control, improving patient comfort and functional mobility. It should be used under medical supervision, considering contraindications such as hypersensitivity to any component, severe hepatic or renal impairment, and history of seizures. Caution is advised when administered with other CNS depressants or serotonergic drugs to avoid adverse effects. Adherence to prescribed dosage is essential to minimize risks of gastrointestinal irritation, sedation, or dependency.